# Clustering Approach 3 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0194909093974993	Range of duration = 0.03 to 223.96, nDeath = 60, nCensor = 128
2	AGE	ANOVA	0.334339106904805	Range of values = 40 to 86, Mean = 65.3032, StdDev = 9.83003, nMissing = 28
3	GENDER	Fisher's exact test	0.0210010519102965	nTypes = 2 (FEMALE/MALE), nPatients = 115/101
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.678735091106815	Range of values = 0 to 100, Mean = 71.1111, StdDev = 34.2807, nMissing = 198
5	HISTOLOGICAL.TYPE	Chi-square test	0.214890030438399	nTypes = 11 (LUNG ACINAR ADENOCARCINOMA/LUNG ADENOCARCINOMA MIXED SUBTYPE/LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS)/LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS/LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS/LUNG CLEAR CELL ADENOCARCINOMA/LUNG MICROPAPILLARY ADENOCARCINOMA/LUNG MUCINOUS ADENOCARCINOMA/LUNG PAPILLARY ADENOCARCINOMA/LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA/MUCINOUS (COLLOID) ADENOCARCINOMA), nPatients = 5/49/132/3/9/1/2/2/9/1/3
6	PATHOLOGY.T	Chi-square test	0.873389618132147	nTypes = 4 (T1/T2/T3/T4), nPatients = 60/125/17/12, nMissing = 2
7	PATHOLOGY.N	Chi-square test	0.401056233921999	nTypes = 3 (N0/N1/N2+N3), nPatients = 125/44/42, nMissing = 5
8	PATHOLOGICSPREAD(M)	Chi-square test	0.289718105594966	nTypes = 3 (M0/M1/MX), nPatients = 139/10/61, nMissing = 6
9	TUMOR.STAGE	Chi-square test	0.677035029522426	nTypes = 4 (I/II/III/IV), nPatients = 107/47/46/11, nMissing = 5
10	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.0191954363785378	nTypes = 2 (NO/YES), nPatients = 9/207
11	NEOADJUVANT.THERAPY	Fisher's exact test	0.2455021177466	nTypes = 2 (NO/YES), nPatients = 31/185